We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPY icon
1001
Amplify Energy
AMPY
$152M
$435K 0.03%
+69,788
New +$379K
IBRX icon
1002
ImmunityBio
IBRX
$7.12B
$435K 0.03%
56,660
+40,700
+255% +$279K
TAYD icon
1003
Taylor Devices
TAYD
$181M
$435K 0.03%
7,638
DTE icon
1004
DTE Energy
DTE
$30.7B
$434K 0.03%
2,970
-14,132
-83% -$1.99M
CI icon
1005
Cigna
CI
$79.5B
$433K 0.03%
1,624
-560
-26% -$155K
VIOO icon
1006
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.17B
$433K 0.03%
3,768
+1,230
+48% +$144K
XYZ
1007
Block Inc
XYZ
$49.1B
$433K 0.03%
7,195
+3,709
+106% +$226K
MSCI icon
1008
MSCI
MSCI
$42.4B
$432K 0.03%
+802
New +$452K
TNDM icon
1009
Tandem Diabetes Care
TNDM
$1.22B
$432K 0.03%
22,536
-8,648
-28% -$188K
DSP icon
1010
Viant Technology
DSP
$226M
$428K 0.03%
38,187
-15,316
-29% -$169K
PLTR icon
1011
Palantir
PLTR
$297B
$427K 0.03%
2,921
-764
-21% -$117K
ACCO icon
1012
Acco Brands
ACCO
$401M
$426K 0.03%
141,839
+100,621
+244% +$379K
ENPH icon
1013
Enphase Energy
ENPH
$4.8B
$426K 0.03%
+11,269
New +$468K
IVVD icon
1014
Invivyd
IVVD
$176M
$426K 0.03%
327,464
-49,148
-13% -$90.3K
BDX icon
1015
Becton Dickinson
BDX
$45.4B
$425K 0.03%
+2,700
New +$496K
GH icon
1016
Guardant Health
GH
$19.2B
$425K 0.03%
4,600
+72
+2% +$7.23K
NMRA icon
1017
Neumora Therapeutics
NMRA
$302M
$425K 0.03%
217,950
-316,094
-59% -$819K
NUE icon
1018
Nucor
NUE
$60.1B
$425K 0.03%
+2,516
New +$439K
PRMB
1019
Primo Brands
PRMB
$8.49B
$425K 0.03%
22,581
-20,385
-47% -$394K
ICFI icon
1020
ICF International
ICFI
$1.53B
$424K 0.03%
+6,500
New +$528K
ALB icon
1021
Albemarle
ALB
$13.4B
$422K 0.03%
+2,348
New +$401K
FBP icon
1022
First Bancorp
FBP
$4.44B
$421K 0.03%
+19,707
New +$424K
CCOI icon
1023
Cogent Communications
CCOI
$641M
$420K 0.03%
+22,317
New +$492K
RSKD icon
1024
Riskified
RSKD
$717M
$419K 0.03%
+106,953
New +$474K
VERU icon
1025
Veru
VERU
$35.8M
$419K 0.03%
189,699
-5,997
-3% -$14.6K

Similar funds

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.